Clinical trial
Randomized, Evaluator-blind, Controlled Trial to Evaluate the Efficacy and Safety of Prostatic Arterial Embolization Versus a Sham Procedure for Benign Prostatic Hyperplasia With Severe LUTS Not Adequately Controlled With Alpha-blockers
NCT02074644 is registered in ClinicalTrials.gov with João Martins Pisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Evaluator-blind, Controlled Trial to Evaluate the Efficacy and Safety of Prostatic Arterial Embolization Versus a Sham Procedure for Benign Prostatic Hyperplasia With Severe LUTS Not Adequately Controlled With Alpha-blockers
- Lead sponsor
- João Martins Pisco
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 2, 2014
- Completion date
- March 3, 2019
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
genital diseases, male, lower urinary tract symptoms, prostatic diseases, prostatic hyperplasia, benign, prostatic hypertrophy, benign